IL281516A - Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness - Google Patents

Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Info

Publication number
IL281516A
IL281516A IL281516A IL28151621A IL281516A IL 281516 A IL281516 A IL 281516A IL 281516 A IL281516 A IL 281516A IL 28151621 A IL28151621 A IL 28151621A IL 281516 A IL281516 A IL 281516A
Authority
IL
Israel
Prior art keywords
eye
damage
treatment
preparations
dryness symptoms
Prior art date
Application number
IL281516A
Other languages
English (en)
Hebrew (he)
Original Assignee
Novaliq Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaliq Gmbh filed Critical Novaliq Gmbh
Publication of IL281516A publication Critical patent/IL281516A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL281516A 2018-09-22 2021-03-15 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness IL281516A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18196126 2018-09-22
EP18198440 2018-10-03
EP18202041 2018-10-23
PCT/EP2019/075406 WO2020058504A1 (en) 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Publications (1)

Publication Number Publication Date
IL281516A true IL281516A (en) 2021-04-29

Family

ID=68240699

Family Applications (1)

Application Number Title Priority Date Filing Date
IL281516A IL281516A (en) 2018-09-22 2021-03-15 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Country Status (11)

Country Link
US (2) US20210346313A1 (https=)
EP (1) EP3852734A1 (https=)
JP (1) JP2022500461A (https=)
KR (1) KR20210080388A (https=)
CN (1) CN112739335A (https=)
AU (2) AU2019342426A1 (https=)
CA (1) CA3111873A1 (https=)
IL (1) IL281516A (https=)
PH (1) PH12021550621A1 (https=)
SG (1) SG11202102818YA (https=)
WO (1) WO2020058504A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110403923B (zh) 2015-09-30 2021-09-21 诺瓦利克有限责任公司 半氟化化合物和其组合物
PT3442480T (pt) 2016-06-23 2019-12-23 Novaliq Gmbh Método de administração tópica
CA3036297C (en) 2016-09-22 2023-09-05 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
WO2018055101A1 (en) 2016-09-23 2018-03-29 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
EP4374851B1 (en) 2016-12-23 2026-04-15 Novaliq GmbH Ophthalmic composition for treatment of dry eye disease
CA3058097C (en) 2017-04-21 2024-01-02 Novaliq Gmbh Iodine compositions
MX2020003534A (es) 2017-09-27 2020-07-29 Novaliq Gmbh Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
WO2019068763A1 (en) 2017-10-04 2019-04-11 Novaliq Gmbh OPHTHALMIC COMPOSITIONS COMPRISING F6H8
KR20200128407A (ko) 2018-03-02 2020-11-12 노바리크 게엠베하 네비볼롤을 포함하는 약제학적 조성물
SG11202007860XA (en) 2018-03-28 2020-09-29 Novaliq Gmbh Pharmaceutical composition comprising timolol
CN112153970A (zh) 2018-04-27 2020-12-29 诺瓦利克有限责任公司 用于治疗青光眼的包含他氟前列素的眼用组合物
EP3923907B1 (en) 2019-02-13 2024-09-25 Novaliq GmbH Compositions and methods for the treatment of ocular neovascularization
KR20220058577A (ko) 2019-09-06 2022-05-09 노바리크 게엠베하 포도막염 치료를 위한 안과용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938668B4 (de) 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
EP2187900B1 (en) * 2007-08-16 2016-11-09 The Schepens Eye Research Institute, Inc. Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
EP2335735A1 (en) 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
AU2013314303B2 (en) * 2012-09-12 2018-01-18 Novaliq Gmbh Semifluorinated alkane compositions
CN113679699B (zh) * 2012-09-12 2022-10-28 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
JP5982070B1 (ja) * 2014-10-09 2016-08-31 株式会社メディプロデュース まつ毛用洗浄剤
CN110403923B (zh) * 2015-09-30 2021-09-21 诺瓦利克有限责任公司 半氟化化合物和其组合物
CA3036297C (en) * 2016-09-22 2023-09-05 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
WO2019068763A1 (en) * 2017-10-04 2019-04-11 Novaliq Gmbh OPHTHALMIC COMPOSITIONS COMPRISING F6H8

Also Published As

Publication number Publication date
KR20210080388A (ko) 2021-06-30
SG11202102818YA (en) 2021-04-29
PH12021550621A1 (en) 2022-02-14
CN112739335A (zh) 2021-04-30
AU2025204313A1 (en) 2025-06-26
AU2019342426A1 (en) 2021-05-20
EP3852734A1 (en) 2021-07-28
US20250295607A1 (en) 2025-09-25
US20210346313A1 (en) 2021-11-11
WO2020058504A1 (en) 2020-03-26
CA3111873A1 (en) 2020-03-26
JP2022500461A (ja) 2022-01-04

Similar Documents

Publication Publication Date Title
IL281516A (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
IL280483A (en) Muscle targeting complexes and uses thereof for treating pompe disease
IL269490B (en) Surface treatment methods and compositions therefor
IL269150A (en) Compositions and methods for treating cancer
EP3678653A4 (en) PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE CARRIER PROTEIN CONJUGATES
EP3678654A4 (en) PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE CARRIER PROTEIN CONJUGATES
EP3678652A4 (en) PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE CARRIER PROTEIN CONJUGATES
IL268814A (en) Compositions and methods for treatment of cancer
PL3896064T3 (pl) Pochodne 4,6-diamino-chinolino-3-karbonitrylu jako modulatory cot w leczeniu choroby leśniowskiego-crohna i wrzodziejącego zapalenia jelita grubego
IL254148A0 (en) Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
SI3775909T1 (sl) Sredstva in postopki za glikoprofiliranje proteina
HUE058931T2 (hu) Pilokarpin hidroklorid alkalmazása presbyopia kezelésére
PL3303632T3 (pl) Terapeutyczne i diagnostyczne sposoby stosowane w nowotworze
SI3240554T1 (sl) Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni
IL269158A (en) Compositions and methods for treating inflammatory diseases
IL258706A (en) Ametropia treatment tracking methods and system
HUE059050T2 (hu) Aminosavakat tartalmazó készítmények mitokondriális rendellenességgel összefüggõ betegségek kezelésében történõ alkalmazásra
IL280827A (en) Integrin alpha 4 antagonists and compositions comprising same for use in treating ocular conditions
PT3681857T (pt) Fluorofenil-beta-hidroxietilaminas e sua utilização no tratamento de hiperglicemia
IL283942A (en) Tubulysins and protein-tubulysin conjugates
IL280348A (en) Surface treatment compositions and methods
IL264070A (en) Methods and compositions for treatment of disorders and diseases involving rdh12
IL286890A (en) Mitochondrial transplantation and use thereof in ocular diseases
PL3732294T3 (pl) Tymohydrochinon do stosowania w leczeniu hiperglikemii
HUE060882T2 (hu) Naftiridinon-származékok és alkalmazásuk arrhytmia kezelésében